ijms-logo

Journal Browser

Journal Browser

Nanomaterials in Tissue Engineering and Regenerative Medicine: Recent Advances and Future Prospects

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 11

Special Issue Editor


E-Mail Website
Guest Editor
John Curtin School of Medical Research (JCSMR), Australian National University, Canberra, ACT 2601, Australia
Interests: nanomaterials; drug delivery; tissue engineering; biomaterial; mechanobiology; cancer theranostics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Nanomaterials have emerged as robust components in tissue engineering and regenerative medicine due to their ability to mimic the structural, mechanical, and biochemical features of native extracellular matrices (ECMs). Their nanoscale dimensions allow precise modulation of cell adhesion, proliferation, differentiation, and signaling, making them ideal candidates for engineering functional tissues and promoting the repair of damaged organs. Recent advances highlight diverse classes of nanomaterials, including nanoparticles, nanofibers, nanotubes, nanocomposites, and nanostructured hydrogels, tailored to support cellular processes. Electrospun nanofiber scaffolds, for example, provide high surface area and topographical cues that direct stem cell fate and enhance tissue regeneration. Carbon-based nanomaterials such as graphene and carbon nanotubes have been incorporated into scaffolds to improve electrical conductivity, which is particularly valuable for neural and cardiac tissue engineering. Inorganic nanomaterials, including bioactive ceramics and metallic nanoparticles, are increasingly used to reinforce mechanical strength and impart osteoinductive and antimicrobial properties, especially in bone regeneration. Nanostructured hydrogels and self-assembling peptide nanomaterials offer tunable porosity and bioactivity, enabling controlled delivery of growth factors, genes, and therapeutic agents at injury sites.

Despite these promising developments, several challenges remain before clinical translation can be achieved. Key concerns include long-term biocompatibility, potential cytotoxicity, immune responses, and the reproducibility of large-scale synthesis. Regulatory hurdles surrounding safety evaluation also slow clinical progress. Furthermore, the integration of nanomaterials into complex 3D-bioprinted constructs and organoid systems is still in an early stage, and better strategies are required to couple nanoscale cues with macroscale tissue organization. Looking forward, the convergence of nanotechnology with advanced fabrication techniques, such as 3D bioprinting, microfluidics, and organ-on-chip platforms, is expected to revolutionize the field. Smart nanomaterials capable of responding to physiological stimuli, releasing therapeutic factors in a spatiotemporally controlled manner, and integrating with host vasculature and immune systems will play a central role in next-generation therapies. By addressing current safety and translational barriers, nanomaterials hold the potential to transform regenerative medicine from experimental models to clinically viable solutions for repairing and replacing damaged tissues.

Dr. Kapil D. Patel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanoparticles
  • nanofibers
  • nanotubes
  • nanocomposites
  • hydrogels
  • ceramics
  • bioactive glass nanoparticles
  • tissue engineering
  • regenerative medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop